1. Home
  2. RUN vs NBTX Comparison

RUN vs NBTX Comparison

Compare RUN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RUN

Sunrun Inc.

HOLD

Current Price

$9.36

Market Cap

2.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$42.74

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
NBTX
Founded
2007
2003
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
RUN
NBTX
Price
$9.36
$42.74
Analyst Decision
Buy
Strong Buy
Analyst Count
20
1
Target Price
$18.80
$36.00
AVG Volume (30 Days)
9.4M
135.5K
Earning Date
05-06-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
113.35
N/A
EPS
1.04
N/A
Revenue
$858,578,000.00
N/A
Revenue This Year
$2.81
$58.17
Revenue Next Year
$4.54
N/A
P/E Ratio
$9.42
N/A
Revenue Growth
12.97
N/A
52 Week Low
$8.61
$8.03
52 Week High
$22.44
$57.14

Technical Indicators

Market Signals
Indicator
RUN
NBTX
Relative Strength Index (RSI) 41.65 61.82
Support Level $9.31 $34.97
Resistance Level $11.19 $57.14
Average True Range (ATR) 0.59 2.21
MACD 0.06 0.66
Stochastic Oscillator 40.31 87.61

Price Performance

Historical Comparison
RUN
NBTX

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: